Fully automated station for testing, characterizing and modifying screen-printed electrodes.

Electrochemical detection systems that provide either quantitative or sample-to-answer information are promising for various analytical applications in the emerging field of point-of-care testing (POCT). Nevertheless, in mobile POC systems optical detection is currently more preferred compared to electrochemical detection due to the insufficient robustness of electrochemical detection approaches toward "real world" use. Over the last couple of decades, screen-printed electrodes (SPEs) have emerged as a simple and low-cost electrochemical detection platform. Here, we report, firstly and solely, a novel benchtop system for the processing of electrochemical methods on SPE platforms. Our solution prevents operator errors from occurring while processing and testing SPEs, achieves an automatic processing of more than 300 electrodes per day and enables comparative testing due to the presence of two simultaneous working channels; furthermore, the SPEs used can be stored in specially-designed cartridges. This novel device helps to overcome the major disadvantages in processing SPE technology, such as a low level of automation and issues with process repeatability, making this technology more efficient and enabling faster growth in industry.

COVID-19: A challenge for electrochemical biosensors.

Coronavirus disease (COVID-19) caused by SARS-CoV-2 has spread since the end of 2019 and has resulted in a pandemic with unprecedented socioeconomic consequences. This situation has created enormous demand for the improvement of current diagnostic methods and the development of new diagnostic methods for fast, low-cost and user-friendly confirmation of SARS-CoV-2 infection. This critical review focuses on viral electrochemical biosensors that are promising for the development of rapid medical COVID-19 diagnostic tools. The molecular biological properties of SARS-CoV-2 as well as currently known biochemical attributes of infection necessary for biosensor development are outlined. The advantages and drawbacks of conventional diagnostic methods, such as quantitative reverse-transcription polymerase chain reaction (qRT-PCR), are critically discussed. Electrochemical biosensors focusing on viral nucleic acid and whole viral particle detection are highlighted and discussed in detail. Finally, future perspectives on viral electrochemical biosensor development are briefly mentioned.